Infectious Disease Transmission, Vertical
-
Subject Areas on Research
-
"At home, no one knows": A qualitative study of retention challenges among women living with HIV in Tanzania.
-
A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children.
-
A counseling intervention to address HIV stigma at entry into antenatal care in Tanzania (Maisha): study protocol for a pilot randomized controlled trial.
-
A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program.
-
A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period.
-
Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project.
-
Accurate Dosing of Antiretrovirals at Home Using a Foilized, Polyethylene Pouch to Prevent the Transmission of HIV From Mother to Child.
-
Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania.
-
Advances and failures in preventing perinatal human immunodeficiency virus infection.
-
Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
-
An intracardiac mass in a young man with congenitally acquired HIV.
-
Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.
-
Antibiotic stewardship: reassessment of guidelines for management of neonatal sepsis.
-
Antibodies for prevention of mother-to-child transmission of HIV-1.
-
Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1.
-
Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV.
-
Attitudes Toward Long-Term Use of Antiretroviral Therapy Among HIV-Infected Pregnant Women in Moshi, Tanzania: A Longitudinal Study.
-
Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol.
-
Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.
-
Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins.
-
Breast Milk of HIV-Positive Mothers Has Potent and Species-Specific In Vivo HIV-Inhibitory Activity.
-
Case 1: Eye Discharge in a 10-day-old Neonate Born by Cesarean Delivery.
-
Change point testing in logistic regression models with interaction term.
-
Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.
-
Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.
-
Chikungunya Fever: Obstetric Considerations on an Emerging Virus.
-
Choice of Study Populations for Vaccines.
-
Clinical characteristics and response to prophylactic fluconazole of preterm VLBW neonates with baseline and acquired fungal colonisation in NICU: data from a multicentre RCT.
-
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
-
Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.
-
Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China.
-
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies.
-
Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025.
-
Considerations for Obstetric Care during the COVID-19 Pandemic.
-
Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
-
Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages.
-
Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis.
-
Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.
-
Detection and Prevention of Perinatal Infection: Cytomegalovirus and Zika Virus.
-
Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.
-
Diagnosis and antenatal management of congenital cytomegalovirus infection.
-
Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States.
-
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up.
-
Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies.
-
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.
-
Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia.
-
Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV.
-
Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth.
-
Ethics of placebo-controlled trials of zidovudine to prevent the perinatal transmission of HIV in the Third World.
-
Evaluating congenital syphilis in a reverse sequence testing environment.
-
Exploring patterns and predictors of suicidal ideation among pregnant and postpartum women living with HIV in Kilimanjaro, Tanzania.
-
Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
-
Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.
-
Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.
-
First, do no harm.
-
Group B Streptococci Screening Before Repeat Cesarean Delivery: A Cost-Effectiveness Analysis.
-
Growth and Neurodevelopment Outcomes in HIV-, Tenofovir-, and Efavirenz-Exposed Breastfed Infants in the PMTCT Option B+ Program in Malawi.
-
HIV Disclosure Among Pregnant Women Initiating ART in Cape Town, South Africa: Qualitative Perspectives During the Pregnancy and Postpartum Periods.
-
HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.
-
HIV and pregnancy: considerations for nursing practice.
-
HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.
-
HIV-infected mothers' foci of concern during the viral testing of their infants.
-
HSV: what you need to know to care for your pregnant patient.
-
Helicobacter infection decreases reproductive performance of IL10-deficient mice.
-
Hepatitis B and C viruses in infants and young children.
-
Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors.
-
Hepatitis C in Pregnancy: Review of Current Knowledge and Updated Recommendations for Management.
-
Hepatitis C in pregnancy.
-
Hepatitis C in pregnancy: screening, treatment, and management.
-
Highly efficient maternal-fetal Zika virus transmission in pregnant rhesus macaques.
-
How do North Carolina prenatal care providers counsel and test pregnant women for HIV? Survey measures knowledge of HIV testing benefits.
-
Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
-
Immune-based interventions to prevent postnatal HIV-1 transmission.
-
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.
-
Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques.
-
Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methods.
-
Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials.
-
Infant HIV-1 vaccines: supplementing strategies to reduce maternal-child transmission.
-
Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
-
Infection in late preterm infants.
-
Infectious diseases in pregnancy.
-
Initial multicenter experience with double nucleoside therapy for human immunodeficiency virus infection during pregnancy.
-
Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B.
-
Integration of statistical theory and practical clinical expertise. Polymerase chain reaction testing of the HIV-exposed infant.
-
Intrahost cytomegalovirus population genetics following antibody pretreatment in a monkey model of congenital transmission.
-
Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi.
-
Low rates of child testing for HIV persist in a high-risk area of East Africa.
-
Management of HIV in pregnancy.
-
Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
-
Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants.
-
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.
-
Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.
-
Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.
-
Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study.
-
Maternal acceptance of voluntary human immunodeficiency virus antibody testing during the newborn period with the Guthrie card.
-
Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.
-
Maternal immunisation to improve the health of HIV-exposed infants.
-
Maternal immunization to benefit the mother, fetus, and infant.
-
Microbial Vertical Transmission during Human Pregnancy.
-
Minimizing the Risk of Perinatal Human Immunodeficiency Virus Transmission.
-
New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection.
-
Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques.
-
PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.
-
Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission?
-
Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.
-
Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.
-
Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi.
-
Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.
-
Perinatal transmission and maternal risks of human papillomavirus infection.
-
Pharmacokinetics and tolerance of zidovudine in preterm infants.
-
Pilot Outcomes of Maisha: An HIV Stigma Reduction Intervention Developed for Antenatal Care in Tanzania.
-
Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission.
-
Postnatal Zika virus infection of nonhuman primate infants born to mothers infected with homologous Brazilian Zika virus.
-
Postnatal cytomegalovirus exposure in infants of antiretroviral-treated and untreated HIV-infected mothers.
-
Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.
-
Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania.
-
Premature Rupture of Membranes with Concurrent Viral Infection.
-
Progress in the prevention of mother to child transmission of HIV in three regions of Tanzania: a retrospective analysis.
-
Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.
-
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies.
-
Providing Safe and Effective Preventative Antiretroviral Prophylaxis to HIV-exposed Newborns via a Novel Drug Delivery System in Tanzania.
-
Rapid telomere shortening in children.
-
Recent progress in immune-based interventions to prevent HIV-1 transmission to children.
-
Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules.
-
Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women.
-
Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa.
-
Rift Valley fever virus induces fetal demise in Sprague-Dawley rats through direct placental infection.
-
Risk factors for group B streptococcal disease in neonates of mothers with negative antenatal testing.
-
Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program.
-
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.
-
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.
-
Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
-
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.
-
Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes.
-
Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes.
-
Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk.
-
The Disclosure Dilemma: Willingness to Disclose a Positive HIV Status Among Individuals Preparing for HIV Testing During Antenatal Care in Tanzania.
-
The Impact of Couple HIV Testing and Counseling on Consistent Condom Use Among Pregnant Women and Their Male Partners: An Observational Study.
-
The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells.
-
The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population.
-
The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316.
-
Toward elimination of perinatal HIV transmission: New Jersey hospital barriers to rapid HIV testing in labor and delivery, 2005.
-
Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina.
-
Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.
-
Tuberculosis transmission from a patient with skin lesions and a negative sputum smear.
-
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
-
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant.
-
Vulnerable at Each Step in the PMTCT Care Cascade: High Loss to Follow Up During Pregnancy and the Postpartum Period in Tanzania.
-
When children harbor HIV.
-
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.
-
Zika virus - reigniting the TORCH.
-
Zika virus and its implications on cord blood banking and transplantation.
-
Keywords of People
-
Cohen-Wolkowiez, Michael,
Professor of Pediatrics,
Pediatrics, Infectious Diseases
-
Cunningham, Coleen Kathryn,
Adjunct Professor in the Department of Pediatrics,
Pediatrics
-
Livingston, Elizabeth Gresham,
Professor of Obstetrics and Gynecology,
Obstetrics and Gynecology, Maternal Fetal Medicine